没有热溶剂的交联pH/热敏水凝作为智能药物输送系统
Sanda Bucatariu1, Bogdan Cosman2, Marieta Constantin1
1"Petru Poni" Institute of Macromolecular Chemistry, Grigore Ghica Voda Alley 41A, 700487 Iasi, Romania.
Gels (Basel, Switzerland)
|December 27, 2024
概括
这项研究引入了一种新型的双pH和热反应性水凝,用于向药物输送. 智能水凝可以感知生理变化并控制药物释放,为治疗各种疾病提供了一种新方法.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 身体pH值和温度的不平衡会触发免疫反应,导致自身免疫性疾病,感染,癌症和糖尿病等疾病.
- 正在开发先进的药物输送微器件,如双pH和热响应载体,以响应特定刺激释放药物.
研究的目的:
- 开发一种基于水凝的新型药物输送系统,能够响应pH值和温度变化.
- 创建一个"智能"系统,能够检测生理障碍并相应调节药物释放.
主要方法:
- 通过使用无溶剂的热方法,通过交叉链接聚N-异烯胺-co-N-乙烯胺 (P(NIPAAm-co-HEAAm)) 和聚甲乙烯-高酸 (P(MVE/MA)) 来合成一种新型的水凝.
- 福利埃变换红外 (FTIR) 和质子核磁共振 (1H NMR) 光谱仪被用来分析聚合物和水凝的化学结构.
- 研究了通过与生物分子的静电相互作用在生理条件下恢复热敏度.
主要成果:
- 开发的水凝具有双重的pH值和热敏度.
- 在生理条件下,水凝最初会失去热敏度,但在与特定生物分子相互作用时可以恢复热敏度.
- 该系统展示了通过崩热敏单元来信号生理干扰和控制药物释放的潜力.
结论:
- 这种新的pH/热敏水凝作为生物传感器,检测生理不平衡.
- 这种智能药物输送系统可以根据检测到的刺激动态调节药物释放配置文件.
- 这项研究为各种疾病的先进治疗干预提供了一个有希望的平台.
更多相关视频
12:07Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
Published on: April 16, 2018
13.3K
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
7.6K
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...